Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.
Singer G; Oldt R 3rd; Cohen Y; Wang BG; Sidransky D; Kurman RJ; Shih IeM; Journal Of The National Cancer Institute, 2003, vol. 95, issue 6, p 484, ISSN 00278874. ISBN 00278874.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef